BreitbartW, PassikSD. Psychiatric aspects of palliative care. In: DoyleD, HanksGWC, MacDonaldN (eds). Oxford Textbook of Palliative Medicine. OXford: Oxford University Press, 1993: 609-626.
2.
Depression Guideline Panel. Depression in Primary Care: Volume 1. Detection and Diagnosis. Clinical Practice Guideline, Number 5.Rockville, MD. U.S, Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0550. April 1993.
3.
Depression Guideline Panel. Depression in Primary Care: Volume 2. Treatment of Major Depression. Clinical Practice Guideline, Number 5.Rockville, MD. U.S.Department of Health and Human ServIces, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0551. April 1993.
4.
MassieMJ, HollandJC. Depression and the cancer patient. J Clin Psychiat1990; 51(7 Suppl): 12-17.
5.
Depression Guideline Panel. Depression in Primary Care: Volume 1. Detection and Diagnosis. Clinical Practice Guideline, Number 5. Rockville, MD. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93–0550. April 1993.
6.
Magruder-HabidK, ZungWWK, FeusserJR, AllingWC, SaunderWB, StevensHA. Management of general medical patients with symptoms of depression. Gen Hosp Psychiat1989; 11: 201–206.
7.
BrodyDS, LarsonDB. The role of the primary care physicians in managing depression. J General Intern Med1992; 7: 243–247.
8.
KatholRG, MutgiA, WilliamsJ, ClamonG, NoyesR.Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiat1990; 147: 1021–1024.
9.
CurtisEB, WalshTD. Prescribing practices of a palliative care service. J Pain Symptom Manage1993; 8: 312–316.
10.
FogelBS, MorV.Depressed mood and care preferences in patients with AIDS. Gen Hosp Psychiat1993; 15: 203–207.
11.
MassieMJ, HollandJC. Depression and the cancer patient. J Clin Psychiat1990; 51 (7 Suppl): 12–17.
12.
BukbergJ.Penman D, Holland JC. Depression in hospitalized cancer patients. Psychosom Med1984; 46: 199–212.
13.
DworkinRH, GitlinMJ. Clinical aspects of depression in chronic pain patients. Clin J Pain1991; 7: 79–94.
14.
Drugs that cause psychiatric symptoms. Med Lett Drugs Therapeutics1993; 35 (901):65–70.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd edition revised. Washington, DC: American Psychiatric Press, 1987.
17.
GeringerES, SternTA. Recognition and treatment of depression in the ICU. In: RippeJM. (eds). Intensive Care Medicine, 2nd edition. Boston: Little, Brown, 1991: 1887–1902.
18.
GerberPD, BarrettJE, BarrettJA, OxmanTE. Manheimer E, Smith R, Whiting RD. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med1992; 7: 170–173.
19.
BreitbartW.Suicide in cancer patients. Oncology1987 (April): 1(2): 49–55.
20.
Depression Guideline Panel. Depression in Primary Care: Volume 2. Treatment of Major Depression. Clinical Practice Guideline, Number 5. Rockville, MD. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93–0551. April 1993.
21.
PotterWZ, RudorferMV, ManjiH.The pharmacologic treatment of depression. N Engl J Med1991; 325: 633–642.
22.
MermelsteinHT, LeskoL.Depression in patients with cancer. Psycho-oncology1992; 1: 199–215.
23.
CodyM.Depression and the use of antidepressants in patients with cancer. Palliat Med1990; 4: 271–278.
24.
GregoryRJ, JimersonDC, WaltonBE, DaleyJ, PaulsenRH. Pharmacotherapy of depression the medically ill; Directions for future research. Gen Hosp Psychiat1992; 14: 36–42.
25.
Choice of an antidepressant. Med Lett Drugs Therapeutics1993; 35 (892):25–26.
26.
AlexopoulosGS. Treatment of depression. In: SalzmanC (ed). Clinical Geriatric Psychopharmacology, 2nd edition. Baltimore: Williams & Wilkins, 1992: 137–174.
27.
PaneraiAE, BianchiM.Sacerdote P, Ripamonti C, Ventafridda V, DeConno F. Antidepressants in cancer pain. J Palliat Care1991; 7 (4):42–44.
28.
PopkinMK, CalliesAL, MacKenzieTB. The out-come of antidepressant use in the medically ill. Arch Gen Psychiat1985; 42: 1160–1163.
VentafriddaV, BonezziC, CaraceniA, DeConnoF, GuariseG, RamellaG, SaitaL, SilvaniV, TamburiniM, ToscaniF.Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone. Ital J Neurol Sci1987; 8: 579–587.
31.
EdwardsJG. Selective serotonin reuptake inhibitors. A modest though welcome advance in the treatment of depression. Br Med J1992; 304: 1644–1646.
32.
DeVaneCL. Pharmacokinetics of the selective serotonin reuptake inhibitors. J Clin Psychiat1992; 52(2 suppl): 13–20.
33.
Paroxetine for treatment of depression. Med Lett Drugs Therapeutics1993; 35 (892):24–25.
34.
BermanI, SapersBL, SalzmanC.Sertraline: A new serotonergic antidepressant. Hosp Comm Psychiat1992; 43: 671–672.
35.
SongF, FreemantleN, SehldonTA. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br Med J1993; 306: 683–687.
36.
ShusterJL, SternTA, GreenbergDB. Pros and cons of fluoxetine for the depressed cancer patient. Oncology1992; 6 (11):45–55.
37.
MaxMB, LynchSA, MuirJ, ShoafSE, SmolerB, DubnerR.Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med1992; 326: 1250–1256.
38.
ChiarelloRJ, ColeJO. The use of psychostimulants in general psychiatry: a reconsideration. Arch Gen Psychiat1987; 44: 286–295.
SatelSL, NelsonJC. Stimulants in the treatment of depression: a critical overview. J Clin Psychiat1989; 50: 241–249.
42.
KrausMF, BurchEA. Methylphenidate hydro-chloride as an antidepressant: controversy, case studies, and review. Southern Med J1992; 85: 985–991.
43.
StiebelV, KempK.Long-term methylphenidate use in the medically ill patient with organic mood syndrome. Psychosomatics1990; 31: 454–456.
44.
BrueraE, ChadwickS, BrenneisC, HansonJ, MacDonaldRN. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep1987; 71: 67–70.
45.
BrueraE, BrenneisC, PatersonAH, MacDonaldRN. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manag1989; 4: 3–6.
46.
MasandP, PickettP, MurrayGB. Psychostimulants for secondary depression in medical illness. Psychosomatics1991; 32: 203–208.
47.
BreitbartW, MermelsteinH.Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics1992; 33 (3):352–356.
48.
JamesWA, LippmanS.Bupropion: overview and prescribing guidelines in depression. Southern Med J1991; 84: 222–224.
49.
Bupropion for depression. Med Lett Drugs Therapeutics1989; 31 (804):97–98.
50.
HollandJC, MorrowGR, SchmaleA, DerogatisL, StefanekM, BerensonS, CarpenterPJ, BreitbartW, FeldsteinM.A randomized trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol1991; 9: 1004–1011.